Inst. Brasileiro de Controle Ao Cancer; Oncologia Clinica / Quimioterapia

São Paulo, São Paulo 03102-002

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Metastatic Breast Cancer

Studies at this site

• A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer — Completed
• A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer — Completed